Octav Ginghină - Concepedia

Author

Octav Ginghină

Carol Davila University of Medicine and Pharmacy ORCID

Also Known As

Iosifescu RV, Lunca Sorinel, Maria SAJIN, O Ginghina, O Ginghină, O. Ginghina, O. Ginghină, OCTAV GINGHINA, OCTAV GINGHINĂ, Octav GINGHINA

112

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Carol Davila University of Medicine and Pharmacy University of Bucharest Clinical Emergency Hospital Bucharest University of Crete Universitatea Națională de Știință și Tehnologie Politehnica București

About

Octav Ginghină is an author at Carol Davila University of Medicine and Pharmacy specializing in medicine, pharmacology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	196
2	Engineering	3	3	131
3	Biomedical Engineering	3	3	117
4	Health Sciences	1	1	13
5	Cell Biology	1	1	60

Octav Ginghină

Publications

702

Citations

H-Index

Page 1

	Year	Citations
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study James Glasbey, Adesoji Ademuyiwa, Adewale Adisa, The Lancet Oncology	2021	280
Impact of multicellular tumor spheroids as an in vivo-like tumor model on anticancer drug response Bianca Gălățeanu, Ariana Hudiță, Carolina Negrei, International Journal of Oncology NanotherapeuticsEngineeringMulticellular Tumor SpheroidsBiomedical EngineeringTumor Biology	2016	60
Novel chitosan and bacterial cellulose biocomposites tailored with polymeric nanoparticles for modern wound dressing development Paul Octavian Stãnescu, Ionut‐Cristian Radu, Rebeca Leu Alexa, Drug Delivery	2021	54
Poly(3-hydroxybutyrate-CO-3-hydroxyvalerate) PHBHV biocompatible nanocarriers for 5-FU delivery targeting colorectal cancer Ionut‐Cristian Radu, Ariana Hudiță, Cătălin Zaharia, Drug Delivery EngineeringBiomedical EngineeringNanomedicineOncologyTherapeutic Nanomaterials	2019	46
Poly(HydroxyButyrate-co-HydroxyValerate) (PHBHV) Nanocarriers for Silymarin Release as Adjuvant Therapy in Colo-rectal Cancer Ionut‐Cristian Radu, Ariana Hudiță, Cătălin Zaharia, Frontiers in Pharmacology	2017	41
Colon Cancer Cells Gene Expression Signature As Response to 5- Fluorouracil, Oxaliplatin, and Folinic Acid Treatment Carolina Negrei, Ariana Hudiță, Octav Ginghină, Frontiers in Pharmacology	2016	39
In Vitro Interaction of Doxorubicin-Loaded Silk Sericin Nanocarriers with MCF-7 Breast Cancer Cells Leads to DNA Damage Ionut‐Cristian Radu, Cătălin Zaharia, Ariana Hudiță, Polymers	2021	33
Update on radionuclide therapy in oncology (Review) Cornelia Niţipir, Dana Niculae, Cristina Orlov, Oncology Letters EngineeringTumor BiologyOncologyBrachytherapyTheranostics	2017	25
Bioinspired silk fibroin nano-delivery systems protect against 5-FU induced gastrointestinal mucositis in a mouse model and display antitumor effects on HT-29 colorectal cancer cells <i>in vitro</i> Ariana Hudiță, Ionut‐Cristian Radu, Bianca Gălățeanu, Nanotoxicology	2021	17
A rare case of advanced lung cancer presenting as a symptomatic gastric tumor Cornelia Niţipir, Octav Ginghină, Liliana Gabriela Popa, Molecular and Clinical Oncology Gastric FundusEsophageal CancerRare CaseGastric MetastasesSurgical Pathology	2018	16

Page 1